IDH mutations in glioma result in genome-wide hypermethylation [159, 213], most likely due to effects of 2HG on the ten–eleven translocation methylcytosine dioxygenase (Tet) family of proteins [61, 134, 243]. Here, IDH1 is linked to central nervous system cancer.